Lunai Bioworks Inc.
LNAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $23,657 | $37,985 | $37,012 | $36,896 |
| - Cash | $625 | $93 | $923 | $312 |
| + Debt | $2,707 | $10,173 | $7,031 | $6,366 |
| Enterprise Value | $25,739 | $48,066 | $43,120 | $42,951 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$42 | -$33 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $2,983 | -$126,512 | $410 | -$7,104 |
| % Margin | – | – | – | – |
| Net Income | $2,819 | -$126,732 | $189 | -$7,252 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.13 | -7.61 | 0.012 | -0.4 |
| % Growth | 101.7% | -66,273.9% | 102.9% | – |
| Operating Cash Flow | -$1,349 | -$1,811 | -$1,487 | -$2,560 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,349 | -$1,811 | -$1,487 | -$2,560 |